Analysis of the delta F508 mutation in a Brazilian cystic fibrosis population: comparison of pulmonary status of homozygotes with other patients.

作者: P.J.C. Maróstica , S. Raskin , F.A. Abreu-e-Silva

DOI: 10.1590/S0100-879X1998000400009

关键词:

摘要: Sixty-one cystic fibrosis patients admitted for check-up or antibiotic treatment were enrolled genetic and clinical evaluation. Genetic analysis was performed on blood samples stored neonatal screening cards using PCR techniques to determine the presence of DF508 mutations. Clinical evaluation included Shwachman Chrispin-Norman scores, age at onset symptoms diagnosis, spirometry, awake sleep pulse oximetry, hyponychial angle measurement chronic Pseudomonas aeruginosa colonization. Eighteen (29.5%) homozygous mutation, 26 (42.6%) had one mutation 17 (27.9%) noncarriers, corresponding a 50.8% prevalence in whole population. Analysis by Kruskal-Wallis test comparison status with continuous variables chi-square logistic regression dichotomous showed no significant differences between any two groups = 0.05. We conclude that relation is not associated pulmonary as evaluated above

参考文章(24)
Correlation between genotype and phenotype in patients with cystic fibrosis. The New England Journal of Medicine. ,vol. 330, pp. 866- 866 ,(1994) , 10.1056/NEJM199310283291804
John A. Phillips, Preston W. Campbell, The cystic fibrosis gene and relationships to clinical status. Seminars in Respiratory Infections. ,vol. 7, pp. 150- 157 ,(1992)
Johanna M Rommens, Michael C Iannuzzi, Bat-sheva Kerem, Mitchell L Drumm, Georg Melmer, Michael Dean, Richard Rozmahel, Jeffery L Cole, Dara Kennedy, Noriko Hidaka, Martha Zsiga, Manuel Buchwald, Lap-Chee Tsui, John R Riordan, Francis S Collins, Identification of the cystic fibrosis gene: chromosome walking and jumping Science. ,vol. 245, pp. 1059- 1065 ,(1989) , 10.1126/SCIENCE.2772657
Susanne Lanng, Marianne Schwartz, Birger Thorsteinsson, Christian Koch, Endocrine and exocrine pancreatic function and the ΔF508 mutation in cystic fibrosis Clinical Genetics. ,vol. 40, pp. 345- 348 ,(2008) , 10.1111/J.1399-0004.1991.TB03107.X
Sabina Liechti-Gallati, Irene Bonsall, Naseem Malik, Verena Schneider, Lilliane G Kraemer, Anna Ruedeberg, Hans Moser, Richard Kraemer, Genotype/phenotype association in cystic fibrosis: analyses of the delta F508, R553X, and 3905insT mutations. Pediatric Research. ,vol. 32, pp. 175- 178 ,(1992) , 10.1203/00006450-199208000-00010
BerylJ. Rosenstein, Genotype-phenotype correlations in cystic fibrosis The Lancet. ,vol. 343, pp. 746- 747 ,(1994) , 10.1016/S0140-6736(94)91832-5
Preston W. Campbell, John A. Phillips, M.R.S. Krishnamani, Kimberly J. Maness, Thomas A. Hazinski, Cystic fibrosis: relationship between clinical status and F508 deletion. The Journal of Pediatrics. ,vol. 118, pp. 239- 241 ,(1991) , 10.1016/S0022-3476(05)80490-1
L N al-Jader, A L Meredith, H C Ryley, J P Cheadle, S Maguire, G Owen, M C Goodchild, P S Harper, Severity of chest disease in cystic fibrosis patients in relation to their genotypes. Journal of Medical Genetics. ,vol. 29, pp. 883- 887 ,(1992) , 10.1136/JMG.29.12.883
G. Borgo, P. Gasparini, A. Bonizzato, G. Cabrini, G. Mastella, P. F. Pignatti, Cystic fibrosis: the delta F508 mutation does not lead to an exceptionally severe phenotype. A cohort study European Journal of Pediatrics. ,vol. 152, pp. 1006- 1011 ,(1993) , 10.1007/BF01957227
H.K. Johansen, M. Nir, C. Koch, M. Schwartz, N. Høiby, Severity of cystic fibrosis in patients homozygous and heterozygous for ΔF508 mutation The Lancet. ,vol. 337, pp. 631- 634 ,(1991) , 10.1016/0140-6736(91)92449-C